The kallikrein–kinin system in diabetic nephropathy

This publication has 152 references indexed in Scilit:

• A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy
  Proceedings of the National Academy of Sciences, 2011
• Oxidative Stress and Diabetic Complications
  Circulation Research, 2010
• Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
  Biochemical Journal, 2010
• Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice
  Proceedings of the National Academy of Sciences, 2010
• Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
  Neuropeptides, 2010
• Bradykinin Type 2 Receptor BE1 Genotype Influences Bradykinin-Dependent Vasodilation During Angiotensin-Converting Enzyme Inhibition
  Hypertension, 2008
• The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
  Pharmacological Reviews, 2007
• Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
  Proceedings of the National Academy of Sciences, 2007
• Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism
  Kidney International, 2000
• Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases
  Immunopharmacology, 1996